Similar articles

• Forming a Doctor-Patient Alliance During COVID-19 to Enhance Treatment Outcomes for Obsessive-Compulsive Disorder.

  Stubbe DE. Stubbe DE. Focus (Am Psychiatr Publ). 2021 Oct;19(4):451-454. doi: 10.1176/appi.focus.20210018. Epub 2021 Nov 5. Focus (Am Psychiatr Publ). 2021. PMID: 35747303 Free PMC article. No abstract available.
• Impact of COVID-19 on People With Obsessive-Compulsive Disorder.

  Storch EA. Storch EA. Focus (Am Psychiatr Publ). 2021 Oct;19(4):444-445. doi: 10.1176/appi.focus.20210019. Epub 2021 Nov 5. Focus (Am Psychiatr Publ). 2021. PMID: 35747297 Free PMC article. No abstract available.
• Laboratory response of patients with panic and obsessive-compulsive disorders to 35% CO2 challenges.

  Perna G, Bertani A, Arancio C, Ronchi P, Bellodi L. Perna G, et al. Am J Psychiatry. 1995 Jan;152(1):85-9. doi: 10.1176/ajp.152.1.85. Am J Psychiatry. 1995. PMID: 7802126 Clinical Trial.
• The epidemiology and differential diagnosis of obsessive compulsive disorder.

  Rasmussen SA, Eisen JL. Rasmussen SA, et al. J Clin Psychiatry. 1992 Apr;53 Suppl:4-10. J Clin Psychiatry. 1992. PMID: 1564054 Review.
• The relationship between body dysmorphic disorder and obsessive-compulsive disorder: A systematic review of direct comparative studies.

  Malcolm A, Labuschagne I, Castle D, Terrett G, Rendell PG, Rossell SL. Malcolm A, et al. Aust N Z J Psychiatry. 2018 Nov;52(11):1030-1049. doi: 10.1177/0004867418799925. Epub 2018 Sep 21. Aust N Z J Psychiatry. 2018. PMID: 30238784